Pharmacokinetic assessment (treosulfan)
Patients of the PIP pre-specified age groups were included in the PK sub-study for both pediatric allogeneic HSCT trials MC-FludT.16/NM and MC-FludT.17/M [Pharmacokinetic analyses used the Phoenix™ WinNonlin